Ftse Mib
33.054,14
-0,52%
DAX
18.994,66
-0,03%
S&P 500
5.917,11
0,00%
NASDAQ
18.966,14
-0,11%
Bitcoin
97.683,09
3,52%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Pyxis Oncology Inc (PYXS) Pyxis Oncology Inc (PYXS) Notizie

Pyxis Oncology Inc

PYXS
2,50
-1,32 (-34,55%)
Pre Mercato
Ultimo aggiornamento: 11:42:53
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/11/202422:06EDGAR2Form 8-K - Current report
20/11/202422:05GLOBEPyxis Oncology Announces Favorable Preliminary PYX-201..
12/11/202422:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/11/202413:30GLOBEPyxis Oncology Provides Corporate Update and Reports..
11/11/202413:00GLOBEPyxis Oncology to Host In-Person (NYC) and Virtual Investor..
06/11/202422:36EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
23/10/202422:53EDGAR2Form 8-K - Current report
25/9/202422:08EDGAR2Form DEF 14A - Other definitive proxy statements
13/9/202422:26EDGAR2Form PRE 14A - Other preliminary proxy statements
29/8/202413:30GLOBEPyxis Oncology to Participate in Two Upcoming Investor..
14/8/202422:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202422:19EDGAR2Form 8-K - Current report
14/8/202422:05GLOBEPyxis Oncology Provides Corporate Update and Reports..
29/7/202414:00GLOBEPyxis Oncology to Participate in the BTIG Virtual..
28/6/202422:30GLOBEPyxis Oncology Reports Inducement Grants Under Nasdaq..
12/6/202422:17EDGAR2Form 8-K - Current report
10/6/202413:56EDGAR2Form 8-K - Current report
10/6/202413:30GLOBEPyxis Oncology Expands Board of Directors with Appointment..
07/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202413:30GLOBEPyxis Oncology to Participate in a Fireside Chat at the..
14/5/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202413:55EDGAR2Form 8-K - Current report
14/5/202413:30GLOBEPyxis Oncology Provides Corporate Update and Reports..
09/5/202413:30GLOBEPyxis Oncology to Present at the RBC Capital Markets Global..
28/3/202421:30GLOBEPyxis Oncology Reports Inducement Grants Under Nasdaq..
27/3/202412:30GLOBEPyxis Oncology Obtains $8 Million Payment for the Sale of..
21/3/202412:30GLOBEPyxis Oncology Provides Corporate Update and Reports..
13/3/202413:00GLOBEPyxis Oncology Expands Board of Directors with Appointment..
08/3/202422:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/3/202422:30GLOBEPyxis Oncology to Present at Leerink Global Biopharma..
05/3/202422:45GLOBEPyxis Oncology to Present New PYX-201, PYX-106 and PYX-102..
28/2/202413:02EDGAR2Form 8-K - Current report
27/2/202414:00GLOBEPyxis Oncology Announces $50 Million Private Placement
29/12/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:30GLOBEPyxis Oncology Reports Inducement Grants Under Nasdaq..
06/12/202322:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/11/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202313:22EDGAR2Form 8-K - Current report
28/11/202313:00GLOBEPyxis Oncology Announces Appointment of Ken Kobayashi, M.D.,..
Apertura: Min: Max:
Chiusura: 3,82

La tua Cronologia

NASDAQ
PYXS
Pyxis Oncology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network